Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?
Search

Volume XXIV No. 11 - August 7, 2017

2014’s PAMA Fix Comes Back to Haunt Big Labs

Commentary and Opinion by R. Lewis Dark /

AS YOU READ THE INTELLIGENCE BRIEFINGS IN THIS ISSUE about lab industry efforts to convince Congress, the administration, and the new leaders of the Centers for Medicare and Medicaid Services to delay implementation of the PAMA final rule on market price reporting, keep in mind that—for the nation’s two largest public lab companies—there is plenty […]

To access this post, you must purchase The Dark Report.

2014’s PAMA Fix Comes Back to Haunt Big Labs Read More »

Delay and Fix Is Message From Labs to Congress

Laboratory Billing /

CEO SUMMARY: Only a few months remain before the federal Centers for Medicare and Medicaid Services makes deep price cuts to Medicare Part B clinical laboratory test fees. Before those cuts go into effect, lab associations and lab professionals are educating members of Congress and the new administration about the bias and flaws in CMS’

To access this post, you must purchase The Dark Report.

Delay and Fix Is Message From Labs to Congress Read More »

NILA Asks Labs to Speak about PAMA Rule’s Flaws

Laboratory Billing /

CEO SUMMARY: In a call to action, the National Independent Laboratory Association is urging lab owners, lab managers, and pathologists to educate their members of Congress about the biases and deep flaws built into the final rule for PAMA market price reporting and how the rule will result in reduced access to clinical lab testing

To access this post, you must purchase The Dark Report.

NILA Asks Labs to Speak about PAMA Rule’s Flaws Read More »

LabCorp, Quest Talk about Medicare Lab Price Cuts

Laboratory Billing /

CEO SUMMARY: In an effort to forestall CMS’ efforts to implement the PAMA final rule on market price reporting, Laboratory Corporation of America and Quest Diagnostics are meeting with members of Congress, officials in the administration, and the new leadership of CMS. During recent conference calls, executives at both lab companies shared insights about these

To access this post, you must purchase The Dark Report.

LabCorp, Quest Talk about Medicare Lab Price Cuts Read More »

Issues Encountered with Anthem’s Pre-approval

Genetic Testing /

CEO SUMMARY: Since Anthem and AIM Specialty Health began a prior-authorization program for genetic testing July 1, a Northeast lab has not had any genetic tests approved through the new system. Physicians told the lab that the steps required for prior authorization were disruptive. Those doctors who regularly order genetic tests had not been trained

To access this post, you must purchase The Dark Report.

Issues Encountered with Anthem’s Pre-approval Read More »

LabCorp Spends $1.2 Billion to Acquire UK’s Chiltern

Laboratory Management /

IT IS THE NEXT STEP to continue diversifying its business away from clinical laboratory testing. On July 31, Laboratory Corporation of America announced that it would acquire Chiltern, a specialty contract research organization in London and Wilmington, N.C. LabCorp valued the all-cash transaction at about $1.2 billion and said it would fund the deal with

To access this post, you must purchase The Dark Report.

LabCorp Spends $1.2 Billion to Acquire UK’s Chiltern Read More »

California Pathology Labs to Report Data to State’s Cancer Registry

Pathology Trends /

HEALTHCARE BIG DATA IS ADVANCING in California and all pathologists in the Golden State will be required to submit data to the state’s cancer registry beginning in 2019. California’s new law to support the state’s cancer registry is the latest example of an effort to ensure the timely collection of complete sets of data needed

To access this post, you must purchase The Dark Report.

California Pathology Labs to Report Data to State’s Cancer Registry Read More »

August 7, 2017 Intelligence: Late Breaking Lab News

Late Breaking Lab News /

PAML of Spokane, Washington, was the subject of an unusual public disclosure recently made by Laboratory Corporation of America. The lab company sent a statement to the Spokane Journal of Business stating its plans to make PAML “its primary lab site in the western U.S. for workplace and toxicology testing.” The statement was made to the

To access this post, you must purchase The Dark Report.

August 7, 2017 Intelligence: Late Breaking Lab News Read More »

Facebook-f Twitter Linkedin-in

The Dark Report
1000 N West Street, Suite 1200 Wilmington, Delaware, United States, 19801
Phone: 512-264-7103
Email: info@darkreport.com

© 2025 The Dark Report. All rights reserved. Part of the LabX Media Group

;